Skip to main content
  • Sign in
    Welcome !
    My account
    Logout

ACRES Commercial Realty Corp. (ACR) Stock Forecast 2025 - AI Price Prediction & Analysis

ACRES Commercial Realty Corp. (ACR) AI Stock Price Forecast & Investment Analysis

ACRES Commercial Realty Corp. Stock Price Chart and Technical Analysis

Loading ACRES Commercial Realty Corp. interactive price chart and technical analysis...

ACRES Commercial Realty Corp. (ACR) - Comprehensive Stock Analysis & Investment Research

Deep dive into ACRES Commercial Realty Corp.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about ACRES Commercial Realty Corp., including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For ACRES Commercial Realty Corp.: ACRES Commercial Realty Corp. operates in the Real Estate & Construction sector, making it an emerging small-cap investment.

ACRES Commercial Realty Corp. (Stock Symbol: ACR) is a leading company in the Real Estate & Construction sector , specifically operating within the Real Estate Investment Trusts industry.

The organization employs approximately 2021 professionals worldwide .

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing ACRES Commercial Realty Corp.'s revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For ACRES Commercial Realty Corp.: With $82M in annual revenue and 10.2% net margin, the company demonstrates solid profitability.

Annual Revenue: $82 million generating a 10.2% net profit margin .

Market Capitalization: $151 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): 1.2% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for ACRES Commercial Realty Corp. stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For ACRES Commercial Realty Corp.: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for ACRES Commercial Realty Corp. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: ACRES Commercial Realty Corp.'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For ACRES Commercial Realty Corp.: Strong free cash flow generation demonstrates developing operational efficiency.

ACRES Commercial Realty Corp. strategically competes in the highly dynamic Real Estate Investment Trusts marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company demonstrates robust operational efficiency through strong free cash flow generation of $33 million annually, complemented by impressive -26.6% year-over-year cash flow growth.

The company maintains a healthy 25.1% gross margin, indicating strong pricing power and operational efficiency.

ACRES Commercial Realty Corp. (ACR) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for ACRES Commercial Realty Corp. stock analysis.

Loading ACRES Commercial Realty Corp. comprehensive fundamental analysis and insider trading data...

Deep dive into ACRES Commercial Realty Corp.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if ACRES Commercial Realty Corp. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For ACRES Commercial Realty Corp.: With a P/E ratio of 6.99, the market sees the stock as potentially undervalued.

P/E Ratio 6.99x
P/B Ratio 0.36x
Market Cap $151M
Dividend Yield 0.01%
Book Value/Share $56.88
Revenue/Share $11.05
FCF/Share $3.30
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently ACRES Commercial Realty Corp. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For ACRES Commercial Realty Corp.: An ROE of 1.2% indicates room for improvement in shareholder value creation.

ROE 1.2%
ROA 0.3%
Gross Margin 25.1%
Operating Margin 10.1%
Net Margin 10.2%
EBT Margin 55.5%
Tax Rate 1.2%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess ACRES Commercial Realty Corp.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For ACRES Commercial Realty Corp.:

D/E Ratio 3.68x
Financial Leverage 4.71x
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal ACRES Commercial Realty Corp.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For ACRES Commercial Realty Corp.: Free cash flow of $33M provides flexibility for shareholder returns and growth investments.

Operating Cash Flow $33M
Free Cash Flow $33M
OCF Growth YoY -26.6%
FCF Growth YoY -26.6%
FCF/Sales 78.0%
CapEx/Sales 0.1%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively ACRES Commercial Realty Corp. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For ACRES Commercial Realty Corp.: An asset turnover of 0.02x suggests room for improvement in asset utilization.

Asset Turnover 0.02x
Fixed Assets Turnover 7.0x
Understanding Financial Statement Data

What these metrics mean: Key figures from ACRES Commercial Realty Corp.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For ACRES Commercial Realty Corp.: With annual revenue of $82M, ACRES Commercial Realty Corp. represents a smaller but potentially high-growth operation.

Income Statement ($ Millions)
Total Revenue $82M
SG&A Expense $18M
Cost of Goods Sold $-12M
Balance Sheet Highlights (% Of Assets)
Cash & Short-term Investments 4%
Total Liabilities 79%
Short-term Debt 7%
Accounts Receivable 0%
Dividend & Shareholder Information
Dividends Per Share $0.15
Payout Ratio 0.2%
Shares Outstanding 7M
Growth Metrics (YoY)
EPS Growth 4.4%

Latest ACRES Commercial Realty Corp. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting ACRES Commercial Realty Corp. (ACR) stock price and investment outlook.

📰 We are currently updating our news feed for ACRES Commercial Realty Corp.. Check back soon for the latest market analysis and company updates.

ACRES Commercial Realty Corp. Competitors & Peer Analysis - Real Estate & Construction Sector

Comparative analysis of ACRES Commercial Realty Corp. against industry peers and competitors in the Real Estate & Construction sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
AAT Unlock Forecast - 30 Days FREE Trial $1403M 14.9x 1.2x
ABR Unlock Forecast - 30 Days FREE Trial $2526M 11.8x 0.9x
ABR-PD Unlock Forecast - 30 Days FREE Trial $4014M 18.8x 1.4x
ABR-PE Unlock Forecast - 30 Days FREE Trial $3925M 18.4x 1.3x
ABR-PF Unlock Forecast - 30 Days FREE Trial $4823M 22.6x 1.6x
ACR Unlock Forecast - 30 Days FREE Trial $151M 7.0x 0.4x
ACRE Unlock Forecast - 30 Days FREE Trial $243M 8.5x 0.5x
ACR-PC Unlock Forecast - 30 Days FREE Trial $186M 8.6x 0.4x
ACR-PD Unlock Forecast - 30 Days FREE Trial $159M 7.3x 0.4x
ADC Unlock Forecast - 30 Days FREE Trial $7814M 42.1x 1.4x
ADC-PA Unlock Forecast - 30 Days FREE Trial $1999M 10.8x 0.4x
AGNC Unlock Forecast - 30 Days FREE Trial $10344M 27.4x 1.0x
AGNCL Unlock Forecast - 30 Days FREE Trial $25756M 68.1x 2.5x
AGNCM Unlock Forecast - 30 Days FREE Trial $25678M 67.9x 2.5x
AGNCN Unlock Forecast - 30 Days FREE Trial $26668M 70.6x 2.6x
AGNCO Unlock Forecast - 30 Days FREE Trial $26157M 69.2x 2.5x
AGNCP Unlock Forecast - 30 Days FREE Trial $25886M 68.5x 2.5x
AHR Unlock Forecast - 30 Days FREE Trial $6570M x 2.7x
AHT Unlock Forecast - 30 Days FREE Trial $17M -1.5x -0.1x
AHT-PD Unlock Forecast - 30 Days FREE Trial $56M x x
AHT-PF Unlock Forecast - 30 Days FREE Trial $43M x x
AHT-PG Unlock Forecast - 30 Days FREE Trial $48M x x
AHT-PH Unlock Forecast - 30 Days FREE Trial $44M x x
AHT-PI Unlock Forecast - 30 Days FREE Trial $44M x x
AIV Unlock Forecast - 30 Days FREE Trial $3266M -6.0x 35.6x
ALEX Unlock Forecast - 30 Days FREE Trial $1212M 15.5x 1.2x
ALX Unlock Forecast - 30 Days FREE Trial $1181M 31.6x 8.1x
AMT Unlock Forecast - 30 Days FREE Trial $246958M 191.0x 66.5x
APLE Unlock Forecast - 30 Days FREE Trial $2742M 15.2x 0.9x
ARE Unlock Forecast - 30 Days FREE Trial $16046M 55.8x 0.9x
ARI Unlock Forecast - 30 Days FREE Trial $1347M -9.0x 0.7x
ARR Unlock Forecast - 30 Days FREE Trial $1381M -6.0x 0.8x
ARR-PC Unlock Forecast - 30 Days FREE Trial $1934M x 1.2x
AVB Unlock Forecast - 30 Days FREE Trial $27051M 23.3x 2.3x
BDN Unlock Forecast - 30 Days FREE Trial $633M -5.2x 0.7x
BFS Unlock Forecast - 30 Days FREE Trial $1122M 26.0x 3.5x
BFS-PD Unlock Forecast - 30 Days FREE Trial $808M 18.8x 2.5x
BFS-PE Unlock Forecast - 30 Days FREE Trial $853M 19.8x 2.7x
BHM Unlock Forecast - 30 Days FREE Trial $195M 71.2x 1.4x
BHR Unlock Forecast - 30 Days FREE Trial $497M -3.1x 2.2x
BHR-PB Unlock Forecast - 30 Days FREE Trial $3046M x 13.5x
BHR-PD Unlock Forecast - 30 Days FREE Trial $4086M x 18.2x
BMNM Unlock Forecast - 30 Days FREE Trial $15M x 0.7x
BNL Unlock Forecast - 30 Days FREE Trial $3713M 37.6x 1.3x
BRSP Unlock Forecast - 30 Days FREE Trial $641M -6.6x 0.6x
BRT Unlock Forecast - 30 Days FREE Trial $264M -37.6x 1.4x
BRX Unlock Forecast - 30 Days FREE Trial $8311M 24.8x 2.8x
BXP Unlock Forecast - 30 Days FREE Trial $16473M 3337.9x 3.1x
CBL Unlock Forecast - 30 Days FREE Trial $834M 12.7x 2.9x
CCI Unlock Forecast - 30 Days FREE Trial $46333M 36.6x 6.1x
CDP Unlock Forecast - 30 Days FREE Trial $3330M 22.2x 2.2x
CDR-PB Unlock Forecast - 30 Days FREE Trial $247M 44.7x 11.0x
CDR-PC Unlock Forecast - 30 Days FREE Trial $226M 41.0x 10.1x
CHCT Unlock Forecast - 30 Days FREE Trial $378M -220.9x 0.9x
CHMI Unlock Forecast - 30 Days FREE Trial $84M -9.3x 0.4x
CHMI-PA Unlock Forecast - 30 Days FREE Trial $801M x 3.5x
CHMI-PB Unlock Forecast - 30 Days FREE Trial $855M x 3.7x
CHTH Unlock Forecast - 30 Days FREE Trial $587M x 0.8x
CIM Unlock Forecast - 30 Days FREE Trial $1056M 5.5x 0.4x
CIMN Unlock Forecast - 30 Days FREE Trial $2095M 10.9x 0.8x
CIMO Unlock Forecast - 30 Days FREE Trial $2107M 10.9x 0.8x
CIM-PA Unlock Forecast - 30 Days FREE Trial $1834M 9.5x 0.7x
CIM-PB Unlock Forecast - 30 Days FREE Trial $1990M 10.3x 0.8x
CIM-PC Unlock Forecast - 30 Days FREE Trial $1889M 9.8x 0.7x
CIM-PD Unlock Forecast - 30 Days FREE Trial $1980M 10.3x 0.8x
CIO Unlock Forecast - 30 Days FREE Trial $281M -15.4x 0.5x
CIO-PA Unlock Forecast - 30 Days FREE Trial $1008M x 1.6x
CLDT Unlock Forecast - 30 Days FREE Trial $326M 34.5x 0.4x
CLDT-PA Unlock Forecast - 30 Days FREE Trial $1103M 116.7x 1.5x
CMCT Unlock Forecast - 30 Days FREE Trial $6M -0.1x 0.0x
CMRF Unlock Forecast - 30 Days FREE Trial $1194M x 0.7x
COLD Unlock Forecast - 30 Days FREE Trial $3879M -26.5x 1.3x
CPT Unlock Forecast - 30 Days FREE Trial $11249M 72.1x 2.5x
CSR Unlock Forecast - 30 Days FREE Trial $1153M -74.6x 1.6x
CTO Unlock Forecast - 30 Days FREE Trial $503M 41.8x 0.9x
CTO-PA Unlock Forecast - 30 Days FREE Trial $687M x 1.2x
CTRE Unlock Forecast - 30 Days FREE Trial $6679M 30.4x 2.0x
CUBE Unlock Forecast - 30 Days FREE Trial $9363M 25.0x 3.3x
CUZ Unlock Forecast - 30 Days FREE Trial $4605M 76.5x 1.0x
CXW Unlock Forecast - 30 Days FREE Trial $1964M 18.9x 1.3x
DEI Unlock Forecast - 30 Days FREE Trial $4344M 115.2x 2.2x
DHC Unlock Forecast - 30 Days FREE Trial $978M -1.7x 0.5x
DHCNI Unlock Forecast - 30 Days FREE Trial $4140M -10.4x 2.2x
DLR Unlock Forecast - 30 Days FREE Trial $63125M 45.7x 2.8x
DLR-PJ Unlock Forecast - 30 Days FREE Trial $8437M 6.1x 0.4x
DLR-PK Unlock Forecast - 30 Days FREE Trial $9126M 6.6x 0.4x
DLR-PL Unlock Forecast - 30 Days FREE Trial $8197M 5.9x 0.4x
DOC Unlock Forecast - 30 Days FREE Trial $13931M 84.5x 1.8x
DRH Unlock Forecast - 30 Days FREE Trial $1578M 23.2x 1.0x
DRH-PA Unlock Forecast - 30 Days FREE Trial $5328M 78.5x 3.4x
DTLAP Unlock Forecast - 30 Days FREE Trial $0M x x
DX Unlock Forecast - 30 Days FREE Trial $1376M 41.8x 1.8x
DX-PC Unlock Forecast - 30 Days FREE Trial $M x x
EARN Unlock Forecast - 30 Days FREE Trial $189M -11.6x 0.8x
EGP Unlock Forecast - 30 Days FREE Trial $8753M 37.0x 2.6x
ELME Unlock Forecast - 30 Days FREE Trial $1470M -114.5x 1.4x
ELS Unlock Forecast - 30 Days FREE Trial $13157M 26.3x 7.6x
EPR Unlock Forecast - 30 Days FREE Trial $0M 18.4x 0.0x
EPR-PC Unlock Forecast - 30 Days FREE Trial $M x x
EPR-PE Unlock Forecast - 30 Days FREE Trial $M x x
EPR-PG Unlock Forecast - 30 Days FREE Trial $M x x
EPRT Unlock Forecast - 30 Days FREE Trial $5857M 26.2x 1.5x
EQIX Unlock Forecast - 30 Days FREE Trial $79320M 79.8x 5.6x
ESS Unlock Forecast - 30 Days FREE Trial $17287M 21.6x 3.1x
EXR Unlock Forecast - 30 Days FREE Trial $32321M 33.1x 2.3x
FBRT Unlock Forecast - 30 Days FREE Trial $935M 8.5x 0.6x
FBRT-PE Unlock Forecast - 30 Days FREE Trial $1838M 16.8x 1.2x
FCPT Unlock Forecast - 30 Days FREE Trial $2466M 23.3x 1.7x
FPI Unlock Forecast - 30 Days FREE Trial $521M 53.4x 0.8x
FR Unlock Forecast - 30 Days FREE Trial $6884M 25.4x 2.6x
FREVS Unlock Forecast - 30 Days FREE Trial $0M 0.0x 0.0x
FRT Unlock Forecast - 30 Days FREE Trial $9036M 26.1x 2.8x
FRT-PC Unlock Forecast - 30 Days FREE Trial $1943M 5.6x 0.6x
FSP Unlock Forecast - 30 Days FREE Trial $156M -1.9x 0.3x
FVR Unlock Forecast - 30 Days FREE Trial $510M x 1.4x
GIPR Unlock Forecast - 30 Days FREE Trial $-146M -0.8x 17.0x
GLPI Unlock Forecast - 30 Days FREE Trial $13766M 19.2x 3.0x
GMRE Unlock Forecast - 30 Days FREE Trial $2149M 208.9x 4.3x
GMRE-PA Unlock Forecast - 30 Days FREE Trial $1762M 171.2x 3.5x
GPMT Unlock Forecast - 30 Days FREE Trial $131M -0.9x 0.2x
GPMT-PA Unlock Forecast - 30 Days FREE Trial $953M x 1.6x
GRP-UN Unlock Forecast - 30 Days FREE Trial $2561M x 2.9x
HIW Unlock Forecast - 30 Days FREE Trial $3429M 26.1x 1.5x
HST Unlock Forecast - 30 Days FREE Trial $11253M 17.1x 1.7x
ICRP Unlock Forecast - 30 Days FREE Trial $85M 7.5x 0.4x
ICR-PA Unlock Forecast - 30 Days FREE Trial $194M 17.2x 0.8x
IHT Unlock Forecast - 30 Days FREE Trial $1M -57.7x 0.2x
ILPT Unlock Forecast - 30 Days FREE Trial $633M -2.3x 1.2x
IMPM Unlock Forecast - 30 Days FREE Trial $6M x x
INN Unlock Forecast - 30 Days FREE Trial $856M 99.4x 1.0x
INN-PE Unlock Forecast - 30 Days FREE Trial $3121M 362.4x 3.5x
INN-PF Unlock Forecast - 30 Days FREE Trial $3180M 369.2x 3.6x
IOR Unlock Forecast - 30 Days FREE Trial $75M 12.5x 0.6x
IRT Unlock Forecast - 30 Days FREE Trial $3913M 141.0x 1.1x
IVR Unlock Forecast - 30 Days FREE Trial $485M 12.0x 0.7x
IVR-PC Unlock Forecast - 30 Days FREE Trial $1622M 40.0x 2.3x
IVT Unlock Forecast - 30 Days FREE Trial $2126M 19.0x 1.2x
JBGS Unlock Forecast - 30 Days FREE Trial $1327M -11.3x 0.7x
KBSR Unlock Forecast - 30 Days FREE Trial $45M x 0.2x
KIM Unlock Forecast - 30 Days FREE Trial $14647M 24.5x 1.4x
KIM-PL Unlock Forecast - 30 Days FREE Trial $14571M 24.4x 1.4x
KIM-PM Unlock Forecast - 30 Days FREE Trial $15005M 25.1x 1.4x
KIM-PN Unlock Forecast - 30 Days FREE Trial $40428M 67.6x 3.8x
KRC Unlock Forecast - 30 Days FREE Trial $4892M 22.3x 0.9x
KREF Unlock Forecast - 30 Days FREE Trial $598M 952.5x 0.5x
KREF-PA Unlock Forecast - 30 Days FREE Trial $1412M x 1.1x
KRG Unlock Forecast - 30 Days FREE Trial $4838M 25.9x 1.5x
LAMR Unlock Forecast - 30 Days FREE Trial $12541M 28.5x 13.9x
LFT Unlock Forecast - 30 Days FREE Trial $92M 6.5x 0.4x
LFT-PA Unlock Forecast - 30 Days FREE Trial $1060M 74.5x 4.6x
LINE Unlock Forecast - 30 Days FREE Trial $10245M x 1.2x
LOAN Unlock Forecast - 30 Days FREE Trial $61M 11.0x 1.4x
LTC Unlock Forecast - 30 Days FREE Trial $1723M 20.7x 1.8x
LXP Unlock Forecast - 30 Days FREE Trial $2633M 30.1x 1.3x
LXP-PC Unlock Forecast - 30 Days FREE Trial $14178M 162.1x 6.9x
MAA Unlock Forecast - 30 Days FREE Trial $16339M 28.6x 2.8x
MAA-PI Unlock Forecast - 30 Days FREE Trial $6741M 11.8x 1.1x
MAC Unlock Forecast - 30 Days FREE Trial $4449M -64.7x 1.7x
MDV Unlock Forecast - 30 Days FREE Trial $204M -24.6x 1.2x
MDV-PA Unlock Forecast - 30 Days FREE Trial $359M x 2.2x
MFA Unlock Forecast - 30 Days FREE Trial $959M 7.5x 0.5x
MFAN Unlock Forecast - 30 Days FREE Trial $2650M 20.6x 1.5x
MFAO Unlock Forecast - 30 Days FREE Trial $2666M 20.8x 1.5x
MFA-PB Unlock Forecast - 30 Days FREE Trial $2195M 17.1x 1.2x
MFA-PC Unlock Forecast - 30 Days FREE Trial $2535M 19.7x 1.4x
MITN Unlock Forecast - 30 Days FREE Trial $753M 16.2x 1.4x
MITP Unlock Forecast - 30 Days FREE Trial $754M 16.3x 1.4x
MITT Unlock Forecast - 30 Days FREE Trial $206M 4.5x 0.4x
MITT-PA Unlock Forecast - 30 Days FREE Trial $668M 14.4x 1.3x
MITT-PB Unlock Forecast - 30 Days FREE Trial $633M 13.7x 1.2x
MITT-PC Unlock Forecast - 30 Days FREE Trial $746M 16.1x 1.4x
MKZR Unlock Forecast - 30 Days FREE Trial $128M x 1.9x
MPW Unlock Forecast - 30 Days FREE Trial $3155M -1.3x 0.7x
NHI Unlock Forecast - 30 Days FREE Trial $3462M 24.2x 2.3x
NLCP Unlock Forecast - 30 Days FREE Trial $273M 10.5x 0.7x
NLOP Unlock Forecast - 30 Days FREE Trial $427M x 0.9x
NNN Unlock Forecast - 30 Days FREE Trial $7897M 20.1x 1.8x
NREF Unlock Forecast - 30 Days FREE Trial $269M -28.2x 2.5x
NREF-PA Unlock Forecast - 30 Days FREE Trial $M x x
NTST Unlock Forecast - 30 Days FREE Trial $1538M 1247.7x 1.2x
NXDT Unlock Forecast - 30 Days FREE Trial $161M -1.9x 0.2x
NXDT-PA Unlock Forecast - 30 Days FREE Trial $676M x 0.9x
NXRT Unlock Forecast - 30 Days FREE Trial $797M 16.6x 2.3x
O Unlock Forecast - 30 Days FREE Trial $53552M 58.5x 1.4x
ONL Unlock Forecast - 30 Days FREE Trial $138M -2.5x 0.2x
ORC Unlock Forecast - 30 Days FREE Trial $896M 139.8x 1.0x
OUT Unlock Forecast - 30 Days FREE Trial $3642M 33.9x 6.8x
PCH Unlock Forecast - 30 Days FREE Trial $3286M 78.9x 1.7x
PCOK Unlock Forecast - 30 Days FREE Trial $180M x 5.5x
PEB Unlock Forecast - 30 Days FREE Trial $1266M -21.5x 0.5x
PEB-PE Unlock Forecast - 30 Days FREE Trial $2365M x 0.9x
PEB-PF Unlock Forecast - 30 Days FREE Trial $2414M x 0.9x
PEB-PG Unlock Forecast - 30 Days FREE Trial $2350M x 0.9x
PEB-PH Unlock Forecast - 30 Days FREE Trial $2113M x 0.8x
PECO Unlock Forecast - 30 Days FREE Trial $5308M 77.1x 2.3x
PINE Unlock Forecast - 30 Days FREE Trial $226M 169.3x 1.0x
PKST Unlock Forecast - 30 Days FREE Trial $493M -3.7x 0.7x
PLD Unlock Forecast - 30 Days FREE Trial $115520M 33.5x 2.2x
PLDGP Unlock Forecast - 30 Days FREE Trial $57381M 16.6x 1.1x
PMT Unlock Forecast - 30 Days FREE Trial $1029M 9.8x 0.6x
PMT-PA Unlock Forecast - 30 Days FREE Trial $2101M 20.0x 1.1x
PMT-PB Unlock Forecast - 30 Days FREE Trial $2111M 20.1x 1.1x
PMT-PC Unlock Forecast - 30 Days FREE Trial $1625M 15.5x 0.9x
PMTU Unlock Forecast - 30 Days FREE Trial $2219M 21.1x 1.2x
PMTV Unlock Forecast - 30 Days FREE Trial $2224M 21.2x 1.2x
PMTW Unlock Forecast - 30 Days FREE Trial $2222M 21.1x 1.2x
PSA Unlock Forecast - 30 Days FREE Trial $52372M 28.9x 5.6x
PSA-PF Unlock Forecast - 30 Days FREE Trial $3977M 2.2x 0.4x
PSA-PG Unlock Forecast - 30 Days FREE Trial $3853M 2.1x 0.4x
PSA-PH Unlock Forecast - 30 Days FREE Trial $4310M 2.4x 0.5x
PSA-PI Unlock Forecast - 30 Days FREE Trial $3668M 2.0x 0.4x
PSA-PJ Unlock Forecast - 30 Days FREE Trial $3522M 2.0x 0.4x
PSA-PK Unlock Forecast - 30 Days FREE Trial $3578M 2.0x 0.4x
PSA-PL Unlock Forecast - 30 Days FREE Trial $3440M 1.9x 0.4x
PSA-PM Unlock Forecast - 30 Days FREE Trial $3063M 1.7x 0.3x
PSA-PN Unlock Forecast - 30 Days FREE Trial $2875M 1.6x 0.3x
PSA-PO Unlock Forecast - 30 Days FREE Trial $2890M 1.6x 0.3x
PSA-PP Unlock Forecast - 30 Days FREE Trial $3023M 1.7x 0.3x
PSA-PQ Unlock Forecast - 30 Days FREE Trial $2972M 1.6x 0.3x
PSA-PR Unlock Forecast - 30 Days FREE Trial $2976M 1.6x 0.3x
PSA-PS Unlock Forecast - 30 Days FREE Trial $3086M 1.7x 0.3x
PW Unlock Forecast - 30 Days FREE Trial $3M -0.2x 0.5x
PW-PA Unlock Forecast - 30 Days FREE Trial $15M x 2.5x
RC Unlock Forecast - 30 Days FREE Trial $617M -13.0x 0.3x
RCB Unlock Forecast - 30 Days FREE Trial $4427M -44.3x 2.4x
RCC Unlock Forecast - 30 Days FREE Trial $4466M -45.2x 2.4x
RCD Unlock Forecast - 30 Days FREE Trial $4351M x 2.4x
RC-PC Unlock Forecast - 30 Days FREE Trial $2742M x 1.5x
RC-PE Unlock Forecast - 30 Days FREE Trial $2710M x 1.5x
REXR Unlock Forecast - 30 Days FREE Trial $10159M 32.0x 1.2x
REXR-PB Unlock Forecast - 30 Days FREE Trial $5679M 17.9x 0.6x
REXR-PC Unlock Forecast - 30 Days FREE Trial $5527M 17.4x 0.6x
RHP Unlock Forecast - 30 Days FREE Trial $8704M 32.6x 10.9x
RITM Unlock Forecast - 30 Days FREE Trial $6026M 7.5x 0.8x
RITM-PA Unlock Forecast - 30 Days FREE Trial $14321M 17.9x 1.8x
RITM-PB Unlock Forecast - 30 Days FREE Trial $14221M 17.7x 1.8x
RITM-PC Unlock Forecast - 30 Days FREE Trial $13764M 17.2x 1.7x
RITM-PD Unlock Forecast - 30 Days FREE Trial $13729M 17.1x 1.7x
RLJ Unlock Forecast - 30 Days FREE Trial $1009M 17.5x 0.5x
RLJ-PA Unlock Forecast - 30 Days FREE Trial $3819M 66.1x 1.7x
SAFE Unlock Forecast - 30 Days FREE Trial $1075M 10.5x 0.5x
SBAC Unlock Forecast - 30 Days FREE Trial $19851M 22.6x -5.1x
SBRA Unlock Forecast - 30 Days FREE Trial $4304M 23.6x 1.6x
SELF Unlock Forecast - 30 Days FREE Trial $55M 22.3x 1.2x
SEVN Unlock Forecast - 30 Days FREE Trial $148M 9.5x 0.6x
SITC Unlock Forecast - 30 Days FREE Trial $442M 1.2x 0.9x
SKT Unlock Forecast - 30 Days FREE Trial $3883M 38.7x 6.1x
SLG Unlock Forecast - 30 Days FREE Trial $4647M -33.2x 1.2x
SLG-PI Unlock Forecast - 30 Days FREE Trial $1789M x 0.5x
SQFT Unlock Forecast - 30 Days FREE Trial $74M 1.2x 2.1x
SQFTP Unlock Forecast - 30 Days FREE Trial $195M 24.7x 5.5x
STAG Unlock Forecast - 30 Days FREE Trial $6956M 29.7x 2.0x
STLY Unlock Forecast - 30 Days FREE Trial $22M 35.3x 0.5x
STRW Unlock Forecast - 30 Days FREE Trial $652M 109.6x 42.1x
STSR Unlock Forecast - 30 Days FREE Trial $28M x 0.4x
STWD Unlock Forecast - 30 Days FREE Trial $7059M 19.1x 1.1x
SUI Unlock Forecast - 30 Days FREE Trial $16329M 12.7x 2.2x
SUNS Unlock Forecast - 30 Days FREE Trial $129M 12.9x 0.7x
SVC Unlock Forecast - 30 Days FREE Trial $379M -2.2x 0.5x
TCI Unlock Forecast - 30 Days FREE Trial $391M 59.2x 0.5x
TFSA Unlock Forecast - 30 Days FREE Trial $200M x 0.0x
TPTA Unlock Forecast - 30 Days FREE Trial $559M x 3.3x
TRTX Unlock Forecast - 30 Days FREE Trial $683M 10.2x 0.6x
TRTX-PC Unlock Forecast - 30 Days FREE Trial $1406M 20.9x 1.3x
TWO Unlock Forecast - 30 Days FREE Trial $1289M -55.6x 0.6x
TWOD Unlock Forecast - 30 Days FREE Trial $M x x
TWO-PA Unlock Forecast - 30 Days FREE Trial $M x x
TWO-PB Unlock Forecast - 30 Days FREE Trial $M x x
TWO-PC Unlock Forecast - 30 Days FREE Trial $M x x
UDR Unlock Forecast - 30 Days FREE Trial $15294M 115.9x 4.6x
UHT Unlock Forecast - 30 Days FREE Trial $502M 28.0x 3.0x
UMH Unlock Forecast - 30 Days FREE Trial $1201M 39.4x 1.3x
UMH-PD Unlock Forecast - 30 Days FREE Trial $1911M 62.7x 2.1x
VICI Unlock Forecast - 30 Days FREE Trial $33250M 12.1x 1.2x
VNO Unlock Forecast - 30 Days FREE Trial $9138M 10.5x 1.5x
VNO-PL Unlock Forecast - 30 Days FREE Trial $4090M 4.7x 0.7x
VNO-PM Unlock Forecast - 30 Days FREE Trial $4155M 4.8x 0.7x
VNO-PN Unlock Forecast - 30 Days FREE Trial $4092M 4.7x 0.7x
VNO-PO Unlock Forecast - 30 Days FREE Trial $3415M 3.9x 0.6x
VNORP Unlock Forecast - 30 Days FREE Trial $18865M 21.6x 3.1x
VRE Unlock Forecast - 30 Days FREE Trial $1655M -32.8x 1.5x
VTR Unlock Forecast - 30 Days FREE Trial $31793M 166.3x 2.8x
WELL Unlock Forecast - 30 Days FREE Trial $113256M 100.3x 3.2x
WHLR Unlock Forecast - 30 Days FREE Trial $-21M -9.5x -0.7x
WHLRD Unlock Forecast - 30 Days FREE Trial $-196M -87.1x -4.8x
WHLRL Unlock Forecast - 30 Days FREE Trial $-625M -277.7x -21.2x
WHLRP Unlock Forecast - 30 Days FREE Trial $-23M -10.1x -0.6x
WPC Unlock Forecast - 30 Days FREE Trial $14794M 44.1x 1.8x
WSR Unlock Forecast - 30 Days FREE Trial $603M 17.9x 1.4x
WY Unlock Forecast - 30 Days FREE Trial $17355M 62.2x 1.8x

Frequently Asked Questions - ACRES Commercial Realty Corp. Stock Forecast

How accurate are ACRES Commercial Realty Corp. stock predictions?

Our AI model demonstrates 55% historical accuracy for ACR predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence ACRES Commercial Realty Corp. stock price forecasts?

Our analysis considers ACRES Commercial Realty Corp.'s financial metrics, Real Estate & Construction sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is ACRES Commercial Realty Corp. a good investment in 2025?

Based on our AI analysis, ACRES Commercial Realty Corp. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are ACRES Commercial Realty Corp. forecasts updated?

ACRES Commercial Realty Corp. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced ACRES Commercial Realty Corp. Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for ACRES Commercial Realty Corp. stock.

🎯 Get Premium Analysis 📊 Explore More Stocks

My Portfolio

Investment Dashboard

Loading your portfolio...